BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29447484)

  • 41. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
    Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cationic liposomes as adjuvants for influenza hemagglutinin: more than charge alone.
    Barnier Quer C; Elsharkawy A; Romeijn S; Kros A; Jiskoot W
    Eur J Pharm Biopharm; 2012 Jun; 81(2):294-302. PubMed ID: 22487055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with
    Araújo MV; Santos Júnior SRD; Nosanchuk JD; Taborda CP
    J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33302372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines.
    Yan W; Chen W; Huang L
    Mol Immunol; 2007 Jul; 44(15):3672-81. PubMed ID: 17521728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo.
    Nordly P; Korsholm KS; Pedersen EA; Khilji TS; Franzyk H; Jorgensen L; Nielsen HM; Agger EM; Foged C
    Eur J Pharm Biopharm; 2011 Jan; 77(1):89-98. PubMed ID: 20940050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators.
    Barnier-Quer C; Elsharkawy A; Romeijn S; Kros A; Jiskoot W
    Pharmaceutics; 2013 Jul; 5(3):392-410. PubMed ID: 24300513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine.
    Guy B; Pascal N; Françon A; Bonnin A; Gimenez S; Lafay-Vialon E; Trannoy E; Haensler J
    Vaccine; 2001 Feb; 19(13-14):1794-805. PubMed ID: 11166905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
    Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
    J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
    Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
    Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Essential Role of Host Double-Stranded DNA Released from Dying Cells by Cationic Liposomes for Mucosal Adjuvanticity.
    Tada R; Ohshima A; Tanazawa Y; Ohmi A; Takahashi S; Kiyono H; Kunisawa J; Aramaki Y; Negishi Y
    Vaccines (Basel); 2019 Dec; 8(1):. PubMed ID: 31892192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
    Korsholm KS; Hansen J; Karlsen K; Filskov J; Mikkelsen M; Lindenstrøm T; Schmidt ST; Andersen P; Christensen D
    Vaccine; 2014 Jun; 32(31):3927-35. PubMed ID: 24877765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study.
    Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N
    Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses.
    Ma Y; Zhuang Y; Xie X; Wang C; Wang F; Zhou D; Zeng J; Cai L
    Nanoscale; 2011 May; 3(5):2307-14. PubMed ID: 21499635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
    Ghaffar KA; Marasini N; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Acta Biomater; 2016 Sep; 41():161-8. PubMed ID: 27063491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal Immunization Using CTA1-DD as a Mucosal Adjuvant for an Inactivated Influenza Vaccine.
    Fan XT; Wang YL; Su QD; Qiu F; Yi Y; Jia ZY; Wang DY; Qin K; Zou YN; Bi SL; Shen LP
    Biomed Environ Sci; 2019 Jul; 32(7):531-540. PubMed ID: 31331437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.